{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"central-core-myopathy","columns":[{"gene":"","key":"population-034d032a25afc3b20714","label":"Central core disease","mondoId":"MONDO:0007294","onsetQualifier":null,"originColumnKey":"MONDO:0007294/OMIM:117000","originalViews":[{"key":"MONDO:0007294/OMIM:117000","label":"Central core disease","scopeLabel":"OMIM:117000","sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"recordKeys":["071adc26b015db3312d8e6187b2d581f534f0f7154aeb8cfe7dbe512624b9abb","0f25bdd6a6f18b84c1cf59d78f5ec355642e3e4e6eeb44694aa493eaf67612fe","12b4ea1c08fa3b1c3333325a1c74992456a6a0ada812383b00a13a9ead510a93","158c191c4dd9083129c102483c199241565c793a580d6d972e882da30041d260","1772f52f5ae097baae2eecf49fb9dd6fe878d3ad4d10a346749b239c04f3d9c2","37062a2ab6cdaf0ba1a498dbf7a190fb4b1711d9aab428ceff58b428beb31722","3bee285b1b9e2aec8d4a6c7eb4586dea41628a14d64425d25bccb4e71d02b6cb","3f92c2c3ec794a84ff80df7c551d4e0157ee4d62a38e74c9f1482c40615852bc","43c02fd02f0dec25cb369c2e52c14d1b2ff6d8f6fa4083e66e4b5ed421a85146","4fcb0cf94c3139efcf90610dd7871b8c0966132d6022331fb56024b59d2c76d6","57656eed472f8801ebec48ac0f0c6af157f848762b79492888d944a5ab6f70a6","5f4f14c06642b1983d708b471de113a315ce07a811d864e0230911a35f215e0f","69ad1b9d04a025059063039798c0450af20e7a3531584ca7222a8ebe2577b79e","6a6d9289fba2bb1a004f971b4a5e3b92038520c3e241211c0959ed902e864efc","79c5e32b2d96629036d244429facb124eae7d7c349b3b62d28f62aa2668cfb15","84d8fcf45cfd37e0031beeddae8851065bd38d28d2e4462e67a742962d21201d","a87b32b3945c40015d6ed900402446f26cfeee72c43f99e43e8a0b135a5df76e","d3bc718de9019d0fb279525eb5db53dde6465e9e217bbfcb5b2452963c275599","d516e65b4d2668fc9887590f61f5b5db9ccf39ad322996aa87979b65d9b76a1b","f678c7acf231291e53ca22d9ece230c17d3b3938663db291cf94c56ee925d843"],"recordQualifiers":{},"scopeLabel":"OMIM:117000","sourceIds":["OMIM:117000"],"sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."},{"gene":"","key":"population-31820f7d37a7fa27fd1b","label":"Central core disease","mondoId":"MONDO:0007294","onsetQualifier":null,"originColumnKey":"MONDO:0007294/ORPHA:597","originalViews":[{"key":"MONDO:0007294/ORPHA:597","label":"Central core disease","scopeLabel":"ORPHA:597","sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"recordKeys":["023c9bd32cbaa574c11cc12b561a67c8a3faecc4bf8e99ee34b346e6f45a77c5","0779913006ea2e2daefdc5a2807ea91c5b65be19534a9d58bcbdaa08b69a21b5","1ed6c179df13f1ab11bb2f5a9f9307973da47eab7b27fb55ee3b6860684e2415","1eef498d4bbed7134617e116088d8257e8de812090f96d4b4283f2562a010a24","29a65eb599acd091d7f368f19f8f84c77706e997d1b848665871627007ddf0dc","2ea874a95724b27ebe368da2510d4617481058c6e8e5ea71603f4c94a59b2db4","4516b6590109c23491615a83070ae10a11fc8fa83a8a8329470f868e03fe31cb","4df860c3db46c301af558ad7bfd346e103c9d9ccb28b772d6a88f0f4afbcca1b","539cb4fd54866d74d13618076ac8156ec47f195b1a8cd42eb990f36a7d4a7011","573037d136983791960004702df737f12b85022911a546f4bc15f94a13002c10","5ec58315235daba15fbe62a09bcd252137d75cbd879c8c0b57dd5b5cf3076f4e","60534387982724395e7874d3ebc1bfdbea2c84bff60a201bdc305195a5ccf914","82ad4b0fb198512cb015e1e3ff09e18e5d6d046ef0527bded015f7312f221845","87186cf503014d8586ec0d4c82755fe32f725734c81f765ae270dcff2c52ad72","8f984ebee51ca084ece7ed86ca04d6be49407657727c60d43a98cddbd328635b","98381552bf68e6272bafe195e87c4af69ed76a758b41f2a2a864d5a615435ad3","a7bb1ba24bdcba59136589929efe5a579258cc057d35aa94bef9ffced7f83f38","b222ba2c3c17ced877b8206aac92f24f848ae07b30baee9052dd1ec625a4a270","b416a1d5de4a0af4403e992370ad40209d4602b68b75a3c99108e30e34adb3f2","b5c8cfa49939992ca37889ce3fc53716470ed902128ce7e534479447599eca49","dd6bd54d92ee68692e4fbafaff4754ea5581707882881bec0ce213535b4a7586","ded0614208c096ed1843d13923bb98547260fe4ea3c0fc60cb7f96e0c0395a34","e1a5d3835123df89dade55f30df2784ac4cd74a7b02ded7e5a0e52a26a225f18","f12bd999146bf9faa15195ca2cf7860ca59d54e4148a5aa32cc3de877ec65bfc","f96a16134c2a3ddf90a4e2d70517942ee8a84763ac51d709692539454dc6f5b8"],"recordQualifiers":{},"scopeLabel":"ORPHA:597","sourceIds":["ORPHA:597"],"sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-034d032a25afc3b20714","population-31820f7d37a7fa27fd1b"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0040081","HP:0006466","HP:0002483","HP:0030230","HP:0003687","HP:0001374","HP:0031936"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":15,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":45,"sourceGroups":{"omim":5,"orphanet":25,"published":15}},"features":[{"hpoId":"HP:0040081","label":"Abnormal circulating creatine kinase activity","primary":true},{"hpoId":"HP:0006466","label":"Ankle flexion contracture","primary":true},{"hpoId":"HP:0002483","label":"Bulbar signs","primary":true},{"hpoId":"HP:0030230","label":"Central core regions in muscle fibers","primary":true},{"hpoId":"HP:0003687","label":"Centrally nucleated skeletal muscle fibers","primary":true},{"hpoId":"HP:0001374","label":"Congenital hip dislocation","primary":true},{"hpoId":"HP:0031936","label":"Delayed ability to walk","primary":true},{"hpoId":"HP:0003388","label":"Easy fatigability","primary":false},{"hpoId":"HP:0003236","label":"Elevated circulating creatine kinase activity","primary":false},{"hpoId":"HP:0011968","label":"Feeding difficulties","primary":false},{"hpoId":"HP:0001989","label":"Fetal akinesia sequence","primary":false},{"hpoId":"HP:0003324","label":"Generalized muscle weakness","primary":false},{"hpoId":"HP:0001265","label":"Hyporeflexia","primary":false},{"hpoId":"HP:0001252","label":"Hypotonia","primary":false},{"hpoId":"HP:0003557","label":"Increased variability in muscle fiber diameter","primary":false},{"hpoId":"HP:0001382","label":"Joint hypermobility","primary":false},{"hpoId":"HP:0002751","label":"Kyphoscoliosis","primary":false},{"hpoId":"HP:0002047","label":"Malignant hyperthermia","primary":false},{"hpoId":"HP:0001634","label":"Mitral valve prolapse","primary":false},{"hpoId":"HP:0001270","label":"Motor delay","primary":false},{"hpoId":"HP:0002828","label":"Multiple joint contractures","primary":false},{"hpoId":"HP:0003552","label":"Muscle stiffness","primary":false},{"hpoId":"HP:0001324","label":"Muscle weakness","primary":false},{"hpoId":"HP:0003198","label":"Myopathy","primary":false},{"hpoId":"HP:0003798","label":"Nemaline bodies","primary":false},{"hpoId":"HP:0001319","label":"Neonatal hypotonia","primary":false},{"hpoId":"HP:0002643","label":"Neonatal respiratory distress","primary":false},{"hpoId":"HP:0000602","label":"Ophthalmoplegia","primary":false},{"hpoId":"HP:0003749","label":"Pelvic girdle muscle weakness","primary":false},{"hpoId":"HP:0001763","label":"Pes planus","primary":false},{"hpoId":"HP:0040191","label":"Rectus femoris muscle atrophy","primary":false},{"hpoId":"HP:0002747","label":"Respiratory insufficiency due to muscle weakness","primary":false},{"hpoId":"HP:0002650","label":"Scoliosis","primary":false},{"hpoId":"HP:0003202","label":"Skeletal muscle atrophy","primary":false},{"hpoId":"HP:0001883","label":"Talipes","primary":false},{"hpoId":"HP:0001762","label":"Talipes equinovarus","primary":false},{"hpoId":"HP:0003803","label":"Type 1 muscle fiber predominance","primary":false},{"hpoId":"HP:0030319","label":"Weakness of facial musculature","primary":false}],"ledeHtml":"Central core disease is a disorder that affects muscles used for movement (skeletal muscles). This condition causes muscle weakness that ranges from barely noticeable to very severe. The severity of muscle weakness may differ even among affected members of the same family. Most people with central core disease experience persistent, mild muscle weakness that does not worsen with time. This weakness affects the muscles near the center of the body (proximal muscles), particularly muscles in the shoulders, upper legs, and hips. Muscle weakness in affected infants can delay the development of motor skills such as sitting, standing, and walking; most people with this condition are able to walk independently. Affected individuals may experience muscle pain (myalgia) or extreme fatigue in response to physical activity (exercise intolerance). Central core disease is also associated with eyes that do not look in the same direction (strabismus), a rounded upper back that also curves to the side (kyphoscoliosis), foot deformities, hip dislocation, and joint deformities called contractures that restrict the movement of certain joints. In severe cases, affected infants experience weakness in the muscles of the face, profound low muscle tone (hypotonia), and serious or life-threatening breathing problems. Many people with central core disease also have an increased risk of developing a severe reaction to certain drugs used during surgery and other invasive procedures. This reaction is called malignant hyperthermia. Malignant hyperthermia occurs in response to some anesthetic gases, which are used to block the sensation of pain, either given alone or in combination with a muscle relaxant that is used to temporarily paralyze a person during a surgical procedure. If given these drugs, people at risk of malignant hyperthermia may experience a rapid increase in heart rate (tachycardia) and body temperature (hyperthermia), abnormally fast breathing (tachypnea), muscle rigidity, breakdown of muscle fibers (rhabdomyolysis), and increased acid levels in the blood and other tissues (acidosis). The complications of malignant hyperthermia can be life-threatening unless they are treated promptly. Central core disease gets its name from disorganized areas called central cores, which are typically found in the center of skeletal muscle cells, but can be at the edges or span the length of the cell, in many affected individuals. These abnormal regions can only been seen when muscle tissue is viewed under a microscope. These central cores are often present in cells with few or no mitochondria, which produce energy within cells. Although the presence of central cores can help doctors diagnose central core disease, it is unclear how they are related to muscle weakness and the other features of this condition.","mondoId":"MONDO:0007294","node":{"canonicalSlug":"central-core-myopathy","comparisons":[{"documentSha256":"aff18c2059e0dca51409932e53b967bbca1f560de67b109f7c4d355edc0cad08","key":"legacy-central-core-myopathy","kind":"legacy","label":"central core myopathy","memberIds":["MONDO:0007294"],"mondoId":"MONDO:0007294","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/central-core-myopathy.aff18c2059e0dca51409932e53b967bbca1f560de67b109f7c4d355edc0cad08.json"},{"documentSha256":"8c5ab84f1ba0262adee39d820f3171ae7532044f1eba679eba9ab07b23179410","key":"expanded-myofibrillar-myopathy","kind":"expanded","label":"myofibrillar myopathy","memberIds":["MONDO:0007294","MONDO:0011076","MONDO:0011362","MONDO:0012130","MONDO:0012215","MONDO:0012277","MONDO:0012289","MONDO:0013061","MONDO:0013472","MONDO:0014922","MONDO:0014993","MONDO:0018943","MONDO:0030927","MONDO:0033620","MONDO:0044647","MONDO:0859168","MONDO:0976133"],"mondoId":"MONDO:0018943","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/node-comparison-8c5ab84f1ba0262adee3.8c5ab84f1ba0262adee39d820f3171ae7532044f1eba679eba9ab07b23179410.json"},{"documentSha256":"b1e5f7f43e8f49e0bbae4bc040d5fcaf71a0f64cfc31b221de852ff97503d7cd","key":"expanded-ryr1-related-myopathy","kind":"expanded","label":"RYR1-related myopathy","memberIds":["MONDO:0007294","MONDO:0009712","MONDO:0018528","MONDO:0020485","MONDO:0100150","MONDO:0850415"],"mondoId":"MONDO:0100150","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/node-comparison-b1e5f7f43e8f49e0bbae.b1e5f7f43e8f49e0bbae4bc040d5fcaf71a0f64cfc31b221de852ff97503d7cd.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"summary","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Central core myopathy","originalSourceId":"ORPHA:597","paragraphs":["Central core disease is a disorder that affects muscles used for movement (skeletal muscles). This condition causes muscle weakness that ranges from barely noticeable to very severe. The severity of muscle weakness may differ even among affected members of the same family. Most people with central core disease experience persistent, mild muscle weakness that does not worsen with time. This weakness affects the muscles near the center of the body (proximal muscles), particularly muscles in the shoulders, upper legs, and hips. Muscle weakness in affected infants can delay the development of motor skills such as sitting, standing, and walking; most people with this condition are able to walk independently. Affected individuals may experience muscle pain (myalgia) or extreme fatigue in response to physical activity (exercise intolerance). Central core disease is also associated with eyes that do not look in the same direction (strabismus), a rounded upper back that also curves to the side (kyphoscoliosis), foot deformities, hip dislocation, and joint deformities called contractures that restrict the movement of certain joints. In severe cases, affected infants experience weakness in the muscles of the face, profound low muscle tone (hypotonia), and serious or life-threatening breathing problems. Many people with central core disease also have an increased risk of developing a severe reaction to certain drugs used during surgery and other invasive procedures. This reaction is called malignant hyperthermia. Malignant hyperthermia occurs in response to some anesthetic gases, which are used to block the sensation of pain, either given alone or in combination with a muscle relaxant that is used to temporarily paralyze a person during a surgical procedure. If given these drugs, people at risk of malignant hyperthermia may experience a rapid increase in heart rate (tachycardia) and body temperature (hyperthermia), abnormally fast breathing (tachypnea), muscle rigidity, breakdown of muscle fibers (rhabdomyolysis), and increased acid levels in the blood and other tissues (acidosis). The complications of malignant hyperthermia can be life-threatening unless they are treated promptly. Central core disease gets its name from disorganized areas called central cores, which are typically found in the center of skeletal muscle cells, but can be at the edges or span the length of the cell, in many affected individuals. These abnormal regions can only been seen when muscle tissue is viewed under a microscope. These central cores are often present in cells with few or no mitochondria, which produce energy within cells. Although the presence of central cores can help doctors diagnose central core disease, it is unclear how they are related to muscle weakness and the other features of this condition."],"rawAttribution":"MONDO:0007294","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-21T17:05:41Z","upstream":"GARD:0006014","url":"https://rarediseases.info.nih.gov/diseases/6014"},"ownColumnKeys":["population-034d032a25afc3b20714","population-31820f7d37a7fa27fd1b"],"publication":"published","relationships":[{"kind":"parent","label":"myofibrillar myopathy","mondoId":"MONDO:0018943","slug":"myofibrillar-myopathy"},{"kind":"parent","label":"RYR1-related myopathy","mondoId":"MONDO:0100150","slug":"ryr1-related-myopathy"},{"kind":"parent","label":"TPM2-related myopathy","mondoId":"MONDO:0100196","slug":"tpm2-related-myopathy"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[{"reason":"synonym-scope-not-retained","source":"MedlinePlus","url":"https://medlineplus.gov/genetics/condition/central-core-disease"}],"translation":"pending"},"records":[{"frequencyKind":"range","key":"023c9bd32cbaa574c11cc12b561a67c8a3faecc4bf8e99ee34b346e6f45a77c5","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:597","disease_name":"Central core disease","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002751","is_excluded":false,"label":"Kyphoscoliosis","onset_id":null,"reference":"ORPHA:597","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"071adc26b015db3312d8e6187b2d581f534f0f7154aeb8cfe7dbe512624b9abb","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:117000","disease_name":"Central core disease","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001763","is_excluded":false,"label":"Pes planus","onset_id":null,"reference":"OMIM:117000","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"0779913006ea2e2daefdc5a2807ea91c5b65be19534a9d58bcbdaa08b69a21b5","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:597","disease_name":"Central core disease","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0003552","is_excluded":false,"label":"Muscle stiffness","onset_id":null,"reference":"ORPHA:597","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"0f25bdd6a6f18b84c1cf59d78f5ec355642e3e4e6eeb44694aa493eaf67612fe","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:117000","disease_name":"Central core disease","evidence":"PCS","frequency_raw":"2/2","hpo_id":"HP:0003687","is_excluded":false,"label":"Centrally nucleated skeletal muscle fibers","onset_id":null,"reference":"PMID:11113224","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"12b4ea1c08fa3b1c3333325a1c74992456a6a0ada812383b00a13a9ead510a93","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:117000","disease_name":"Central core disease","evidence":"PCS","frequency_raw":"3/3","hpo_id":"HP:0030230","is_excluded":false,"label":"Central core regions in muscle fibers","onset_id":null,"reference":"PMID:16940308","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"158c191c4dd9083129c102483c199241565c793a580d6d972e882da30041d260","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:117000","disease_name":"Central core disease","evidence":"PCS","frequency_raw":"2/20","hpo_id":"HP:0002047","is_excluded":false,"label":"Malignant hyperthermia","onset_id":null,"reference":"OMIM:117000;PMID:11113224","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"1772f52f5ae097baae2eecf49fb9dd6fe878d3ad4d10a346749b239c04f3d9c2","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:117000","disease_name":"Central core disease","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0003324","is_excluded":false,"label":"Generalized muscle weakness","onset_id":null,"reference":"OMIM:117000","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"1ed6c179df13f1ab11bb2f5a9f9307973da47eab7b27fb55ee3b6860684e2415","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:597","disease_name":"Central core disease","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0003749","is_excluded":false,"label":"Pelvic girdle muscle weakness","onset_id":null,"reference":"ORPHA:597","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"1eef498d4bbed7134617e116088d8257e8de812090f96d4b4283f2562a010a24","raw":{"aspect":"P","body_system":"respiratory","disease_id":"ORPHA:597","disease_name":"Central core disease","evidence":"TAS","frequency_raw":"HP:0040284","hpo_id":"HP:0002643","is_excluded":false,"label":"Neonatal respiratory distress","onset_id":null,"reference":"ORPHA:597","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"29a65eb599acd091d7f368f19f8f84c77706e997d1b848665871627007ddf0dc","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:597","disease_name":"Central core disease","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0040191","is_excluded":true,"label":"Rectus femoris muscle atrophy","onset_id":null,"reference":"ORPHA:597","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"2ea874a95724b27ebe368da2510d4617481058c6e8e5ea71603f4c94a59b2db4","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:597","disease_name":"Central core disease","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000602","is_excluded":false,"label":"Ophthalmoplegia","onset_id":null,"reference":"ORPHA:597","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"37062a2ab6cdaf0ba1a498dbf7a190fb4b1711d9aab428ceff58b428beb31722","raw":{"aspect":"P","body_system":"head_and_neck","disease_id":"OMIM:117000","disease_name":"Central core disease","evidence":"PCS","frequency_raw":"7/8","hpo_id":"HP:0030319","is_excluded":false,"label":"Weakness of facial musculature","onset_id":null,"reference":"PMID:11113224","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"3bee285b1b9e2aec8d4a6c7eb4586dea41628a14d64425d25bccb4e71d02b6cb","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:117000","disease_name":"Central core disease","evidence":"PCS","frequency_raw":"1/4","hpo_id":"HP:0001883","is_excluded":false,"label":"Talipes","onset_id":null,"reference":"PMID:16940308","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"3f92c2c3ec794a84ff80df7c551d4e0157ee4d62a38e74c9f1482c40615852bc","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:117000","disease_name":"Central core disease","evidence":"PCS","frequency_raw":"4/4","hpo_id":"HP:0001319","is_excluded":false,"label":"Neonatal hypotonia","onset_id":"HP:0003623","reference":"PMID:16940308","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"43c02fd02f0dec25cb369c2e52c14d1b2ff6d8f6fa4083e66e4b5ed421a85146","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:117000","disease_name":"Central core disease","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0003803","is_excluded":false,"label":"Type 1 muscle fiber predominance","onset_id":null,"reference":"OMIM:117000","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"4516b6590109c23491615a83070ae10a11fc8fa83a8a8329470f868e03fe31cb","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:597","disease_name":"Central core disease","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001270","is_excluded":false,"label":"Motor delay","onset_id":null,"reference":"ORPHA:597","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"4df860c3db46c301af558ad7bfd346e103c9d9ccb28b772d6a88f0f4afbcca1b","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:597","disease_name":"Central core disease","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001252","is_excluded":false,"label":"Hypotonia","onset_id":null,"reference":"ORPHA:597","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"4fcb0cf94c3139efcf90610dd7871b8c0966132d6022331fb56024b59d2c76d6","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:117000","disease_name":"Central core disease","evidence":"PCS","frequency_raw":"6/12","hpo_id":"HP:0001270","is_excluded":false,"label":"Motor delay","onset_id":null,"reference":"PMID:16940308;PMID:11113224","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"539cb4fd54866d74d13618076ac8156ec47f195b1a8cd42eb990f36a7d4a7011","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:597","disease_name":"Central core disease","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0003798","is_excluded":false,"label":"Nemaline bodies","onset_id":null,"reference":"ORPHA:597","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"573037d136983791960004702df737f12b85022911a546f4bc15f94a13002c10","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:597","disease_name":"Central core disease","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001382","is_excluded":false,"label":"Joint hypermobility","onset_id":null,"reference":"ORPHA:597","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"57656eed472f8801ebec48ac0f0c6af157f848762b79492888d944a5ab6f70a6","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:117000","disease_name":"Central core disease","evidence":"PCS","frequency_raw":"6/8","hpo_id":"HP:0001265","is_excluded":false,"label":"Hyporeflexia","onset_id":null,"reference":"PMID:11113224","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"5ec58315235daba15fbe62a09bcd252137d75cbd879c8c0b57dd5b5cf3076f4e","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:597","disease_name":"Central core disease","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0003198","is_excluded":false,"label":"Myopathy","onset_id":null,"reference":"ORPHA:597","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"5f4f14c06642b1983d708b471de113a315ce07a811d864e0230911a35f215e0f","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:117000","disease_name":"Central core disease","evidence":"PCS","frequency_raw":"5/5","hpo_id":"HP:0003557","is_excluded":false,"label":"Increased variability in muscle fiber diameter","onset_id":null,"reference":"PMID:16940308;PMID:11113224","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"60534387982724395e7874d3ebc1bfdbea2c84bff60a201bdc305195a5ccf914","raw":{"aspect":"P","body_system":"respiratory","disease_id":"ORPHA:597","disease_name":"Central core disease","evidence":"TAS","frequency_raw":"HP:0040284","hpo_id":"HP:0002747","is_excluded":false,"label":"Respiratory insufficiency due to muscle weakness","onset_id":null,"reference":"ORPHA:597","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"69ad1b9d04a025059063039798c0450af20e7a3531584ca7222a8ebe2577b79e","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:117000","disease_name":"Central core disease","evidence":"PCS","frequency_raw":"4/4","hpo_id":"HP:0031936","is_excluded":false,"label":"Delayed ability to walk","onset_id":null,"reference":"PMID:16940308","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"6a6d9289fba2bb1a004f971b4a5e3b92038520c3e241211c0959ed902e864efc","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:117000","disease_name":"Central core disease","evidence":"PCS","frequency_raw":"4/4","hpo_id":"HP:0001324","is_excluded":false,"label":"Muscle weakness","onset_id":"HP:0003623","reference":"PMID:16940308","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"79c5e32b2d96629036d244429facb124eae7d7c349b3b62d28f62aa2668cfb15","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:117000","disease_name":"Central core disease","evidence":"PCS","frequency_raw":"6/8","hpo_id":"HP:0006466","is_excluded":false,"label":"Ankle flexion contracture","onset_id":null,"reference":"PMID:11113224","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"82ad4b0fb198512cb015e1e3ff09e18e5d6d046ef0527bded015f7312f221845","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:597","disease_name":"Central core disease","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0003388","is_excluded":false,"label":"Easy fatigability","onset_id":null,"reference":"ORPHA:597","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"84d8fcf45cfd37e0031beeddae8851065bd38d28d2e4462e67a742962d21201d","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:117000","disease_name":"Central core disease","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0003202","is_excluded":false,"label":"Skeletal muscle atrophy","onset_id":null,"reference":"OMIM:117000","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"87186cf503014d8586ec0d4c82755fe32f725734c81f765ae270dcff2c52ad72","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:597","disease_name":"Central core disease","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001634","is_excluded":false,"label":"Mitral valve prolapse","onset_id":null,"reference":"ORPHA:597","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"8f984ebee51ca084ece7ed86ca04d6be49407657727c60d43a98cddbd328635b","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:597","disease_name":"Central core disease","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0040081","is_excluded":false,"label":"Abnormal circulating creatine kinase activity","onset_id":null,"reference":"ORPHA:597","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"98381552bf68e6272bafe195e87c4af69ed76a758b41f2a2a864d5a615435ad3","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:597","disease_name":"Central core disease","evidence":"TAS","frequency_raw":"HP:0040284","hpo_id":"HP:0003236","is_excluded":false,"label":"Elevated circulating creatine kinase activity","onset_id":null,"reference":"ORPHA:597","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"a7bb1ba24bdcba59136589929efe5a579258cc057d35aa94bef9ffced7f83f38","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:597","disease_name":"Central core disease","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001762","is_excluded":false,"label":"Talipes equinovarus","onset_id":null,"reference":"ORPHA:597","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"a87b32b3945c40015d6ed900402446f26cfeee72c43f99e43e8a0b135a5df76e","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:117000","disease_name":"Central core disease","evidence":"PCS","frequency_raw":"2/2","hpo_id":"HP:0003798","is_excluded":false,"label":"Nemaline bodies","onset_id":null,"reference":"PMID:11113224","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"b222ba2c3c17ced877b8206aac92f24f848ae07b30baee9052dd1ec625a4a270","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:597","disease_name":"Central core disease","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002483","is_excluded":false,"label":"Bulbar signs","onset_id":null,"reference":"ORPHA:597","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"b416a1d5de4a0af4403e992370ad40209d4602b68b75a3c99108e30e34adb3f2","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:597","disease_name":"Central core disease","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002828","is_excluded":false,"label":"Multiple joint contractures","onset_id":null,"reference":"ORPHA:597","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"b5c8cfa49939992ca37889ce3fc53716470ed902128ce7e534479447599eca49","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:597","disease_name":"Central core disease","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0030230","is_excluded":false,"label":"Central core regions in muscle fibers","onset_id":null,"reference":"ORPHA:597","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"d3bc718de9019d0fb279525eb5db53dde6465e9e217bbfcb5b2452963c275599","raw":{"aspect":"P","body_system":"digestive","disease_id":"OMIM:117000","disease_name":"Central core disease","evidence":"PCS","frequency_raw":"4/4","hpo_id":"HP:0011968","is_excluded":false,"label":"Feeding difficulties","onset_id":null,"reference":"PMID:16940308","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"d516e65b4d2668fc9887590f61f5b5db9ccf39ad322996aa87979b65d9b76a1b","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:117000","disease_name":"Central core disease","evidence":"PCS","frequency_raw":"1/8","hpo_id":"HP:0002650","is_excluded":false,"label":"Scoliosis","onset_id":null,"reference":"PMID:11113224","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"dd6bd54d92ee68692e4fbafaff4754ea5581707882881bec0ce213535b4a7586","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:597","disease_name":"Central core disease","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002047","is_excluded":false,"label":"Malignant hyperthermia","onset_id":null,"reference":"ORPHA:597","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"ded0614208c096ed1843d13923bb98547260fe4ea3c0fc60cb7f96e0c0395a34","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:597","disease_name":"Central core disease","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001374","is_excluded":false,"label":"Congenital hip dislocation","onset_id":null,"reference":"ORPHA:597","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"e1a5d3835123df89dade55f30df2784ac4cd74a7b02ded7e5a0e52a26a225f18","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:597","disease_name":"Central core disease","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001763","is_excluded":false,"label":"Pes planus","onset_id":null,"reference":"ORPHA:597","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"f12bd999146bf9faa15195ca2cf7860ca59d54e4148a5aa32cc3de877ec65bfc","raw":{"aspect":"P","body_system":"prenatal","disease_id":"ORPHA:597","disease_name":"Central core disease","evidence":"TAS","frequency_raw":"HP:0040284","hpo_id":"HP:0001989","is_excluded":false,"label":"Fetal akinesia sequence","onset_id":null,"reference":"ORPHA:597","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"f678c7acf231291e53ca22d9ece230c17d3b3938663db291cf94c56ee925d843","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:117000","disease_name":"Central core disease","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001374","is_excluded":false,"label":"Congenital hip dislocation","onset_id":null,"reference":"OMIM:117000","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"f96a16134c2a3ddf90a4e2d70517942ee8a84763ac51d709692539454dc6f5b8","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:597","disease_name":"Central core disease","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0003803","is_excluded":false,"label":"Type 1 muscle fiber predominance","onset_id":null,"reference":"ORPHA:597","source_release":"2026-06-23"},"sourceGroups":["orphanet"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/6014\" rel=\"noreferrer\">GARD</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0007294\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>summary</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>GARD:0006014</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>Central core disease is a disorder that affects muscles used for movement (skeletal muscles). This condition causes muscle weakness that ranges from barely noticeable to very severe. The severity of muscle weakness may differ even among affected members of the same family. Most people with central core disease experience persistent, mild muscle weakness that does not worsen with time. This weakness affects the muscles near the center of the body (proximal muscles), particularly muscles in the shoulders, upper legs, and hips. Muscle weakness in affected infants can delay the development of motor skills such as sitting, standing, and walking; most people with this condition are able to walk independently. Affected individuals may experience muscle pain (myalgia) or extreme fatigue in response to physical activity (exercise intolerance). Central core disease is also associated with eyes that do not look in the same direction (strabismus), a rounded upper back that also curves to the side (kyphoscoliosis), foot deformities, hip dislocation, and joint deformities called contractures that restrict the movement of certain joints. In severe cases, affected infants experience weakness in the muscles of the face, profound low muscle tone (hypotonia), and serious or life-threatening breathing problems. Many people with central core disease also have an increased risk of developing a severe reaction to certain drugs used during surgery and other invasive procedures. This reaction is called malignant hyperthermia. Malignant hyperthermia occurs in response to some anesthetic gases, which are used to block the sensation of pain, either given alone or in combination with a muscle relaxant that is used to temporarily paralyze a person during a surgical procedure. If given these drugs, people at risk of malignant hyperthermia may experience a rapid increase in heart rate (tachycardia) and body temperature (hyperthermia), abnormally fast breathing (tachypnea), muscle rigidity, breakdown of muscle fibers (rhabdomyolysis), and increased acid levels in the blood and other tissues (acidosis). The complications of malignant hyperthermia can be life-threatening unless they are treated promptly. Central core disease gets its name from disorganized areas called central cores, which are typically found in the center of skeletal muscle cells, but can be at the edges or span the length of the cell, in many affected individuals. These abnormal regions can only been seen when muscle tissue is viewed under a microscope. These central cores are often present in cells with few or no mitochondria, which produce energy within cells. Although the presence of central cores can help doctors diagnose central core disease, it is unclear how they are related to muscle weakness and the other features of this condition.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/6014\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Overview"}],"sharedSources":[],"slug":"central-core-myopathy","sourceDocuments":[{"name":"GARD: Central core myopathy","reviewed":null,"source_release":"2026-10-21T17:05:41Z","url":"https://rarediseases.info.nih.gov/diseases/6014"},{"name":"MONDO: central core myopathy","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0007294"}],"sourceNote":"","synonyms":["CCD","Central Core Disease","central core disease","central CORE disease of muscle","muscle core disease","muscular central core disease","myopathy, central core","myopathy, central fibrillar","neuromuscular disease, congenital, with uniform type 1 Fibre","Shy-Magee syndrome"],"takeawayHtml":"","title":"central core myopathy"},"schemaVersion":1}
